Skip to main content

Table 1 Patient demographics and perioperative data

From: Enumeration of circulating endothelial cell frequency as a diagnostic marker in aortic valve surgery - a flow cytometric approach

 

CAVR (n = 11)

TAVI (n = 11)

p-value

Age [yrs]

69.0 ± 11.2

81.0 ± 4.8

0.004

Female [N]

5 (45.5%)

7 (63.6%)

0.670

Height [cm]

175.6 ± 5.0

166.2 ± 9.2

0.011

Weight [kg]

84.9 ± 11.6

65.5 ± 12.4

0.002

Log. euroSCORE

5.33 ± 4.40

19.37 ± 7.05

<0.001

STS score

1.90 ± 1.06

7.85 ± 3.59

<0.001

CAD [N]

4 (36.4%)

8 (72.7%)

0.198

Pre-operative creatinine [mg/dL]

0.92 ± 0.2

1.52 ± 0.9

0.042

Pre-operative hemoglobin [g/dL]

13.8 ± 1.3

11.6 ± 0.9

0.001

Pre-operative CK [U/L]

63.8 ± 24.7

42.0 ± 27.1

0.053

Pre-operative CK-MB [U/L]

6.73 ± 1.6

10.36 ± 5.6

0.053

Pre-operative Troponin T [μg/L]

0.01 ± 0.01

0.08 ± 0.10

0.031

Pre-operative EF [%]

61.9 ± 23.1

49.9 ± 26.0

0.355

Pre-operative AVA [cm2]

0.62 ± 0.30

0.60 ± 0.22

0.922

Pre-operative cardiac decompensation [N]

0

4 (36.4%)

0.045

Arterial hypertension [N]

10 (90.9%)

11 (100.0%)

1.000

Hyperlipoproteinemia [N]

10 (90.9%)

11 (100.0%)

1.000

Pre-operative pulmonary hypertension [N]

0

2 (18.2%)

0.476

Previous statin therapy [N]

10 (90.9%)

11 (100.0%)

1.000

History of AMI [N]

0

1 (9.1%)

0.168

  1. AVA aortic valve area, CAD coronary artery disease, CK creatine kinase, CK-MB creatine kinase-muscle/brain (cardiac specific isoform), EF ejection fraction, AMI acute myocardial infarction
  2. Statistically significant p-values are presented in bold